Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)
Others
Ratios

Solid Biosciences (SLDB) Operating Expenses: 2016-2024

Historic Operating Expenses for Solid Biosciences (SLDB) over the last 9 years, with Dec 2024 value amounting to $129.7 million.

  • Solid Biosciences' Operating Expenses rose 79.19% to $39.9 million in Q4 2024 from the same period last year, while for Dec 2024 it was $129.7 million, marking a year-over-year increase of 24.44%. This contributed to the annual value of $129.7 million for FY2024, which is 24.44% up from last year.
  • Solid Biosciences' Operating Expenses amounted to $129.7 million in FY2024, which was up 24.44% from $104.3 million recorded in FY2023.
  • Over the past 5 years, Solid Biosciences' Operating Expenses peaked at $129.7 million during FY2024, and registered a low of $85.9 million during FY2021.
  • In the last 3 years, Solid Biosciences' Operating Expenses had a median value of $114.5 million in 2022 and averaged $116.2 million.
  • As far as peak fluctuations go, Solid Biosciences' Operating Expenses fell by 25.91% in 2020, and later spiked by 33.39% in 2022.
  • Over the past 5 years, Solid Biosciences' Operating Expenses (Yearly) stood at $88.4 million in 2020, then fell by 2.86% to $85.9 million in 2021, then skyrocketed by 33.39% to $114.5 million in 2022, then decreased by 8.99% to $104.3 million in 2023, then climbed by 24.44% to $129.7 million in 2024.